Oppenheimer & Co’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $437K | Sell |
8,979
-495
| -5% | -$24.1K | 0.01% | 1187 |
|
|
2025
Q1 | $322K | Sell |
9,474
-2,006
| -17% | -$68.3K | ﹤0.01% | 1239 |
|
|
2024
Q4 | $452K | Sell |
11,480
-22,648
| -66% | -$891K | 0.01% | 1103 |
|
|
2024
Q3 | $1.6M | Buy |
34,128
+2,478
| +8% | +$116K | 0.02% | 618 |
|
|
2024
Q2 | $1.71M | Buy |
31,650
+1,958
| +7% | +$106K | 0.03% | 585 |
|
|
2024
Q1 | $2.02M | Buy |
29,692
+3,257
| +12% | +$222K | 0.03% | 512 |
|
|
2023
Q4 | $1.65M | Buy |
26,435
+4,437
| +20% | +$278K | 0.03% | 554 |
|
|
2023
Q3 | $998K | Buy |
21,998
+2,975
| +16% | +$135K | 0.02% | 677 |
|
|
2023
Q2 | $1.07M | Buy |
19,023
+1,079
| +6% | +$60.6K | 0.02% | 682 |
|
|
2023
Q1 | $812K | Sell |
17,944
-802
| -4% | -$36.3K | 0.02% | 765 |
|
|
2022
Q4 | $762K | Sell |
18,746
-1,031
| -5% | -$41.9K | 0.02% | 769 |
|
|
2022
Q3 | $1.29M | Buy |
19,777
+1,574
| +9% | +$103K | 0.03% | 572 |
|
|
2022
Q2 | $1.11M | Buy |
18,203
+1,162
| +7% | +$70.7K | 0.02% | 653 |
|
|
2022
Q1 | $1.07M | Sell |
17,041
-2,256
| -12% | -$142K | 0.02% | 721 |
|
|
2021
Q4 | $1.46M | Sell |
19,297
-1,249
| -6% | -$94.7K | 0.03% | 624 |
|
|
2021
Q3 | $2.3M | Buy |
20,546
+3,367
| +20% | +$377K | 0.04% | 465 |
|
|
2021
Q2 | $2.78M | Buy |
17,179
+6,635
| +63% | +$1.07M | 0.05% | 415 |
|
|
2021
Q1 | $1.29M | Buy |
10,544
+1,456
| +16% | +$177K | 0.03% | 617 |
|
|
2020
Q4 | $1.39M | Sell |
9,088
-263
| -3% | -$40.3K | 0.03% | 540 |
|
|
2020
Q3 | $782K | Sell |
9,351
-639
| -6% | -$53.4K | 0.02% | 669 |
|
|
2020
Q2 | $734K | Sell |
9,990
-850
| -8% | -$62.5K | 0.02% | 681 |
|
|
2020
Q1 | $460K | Buy |
10,840
+6,841
| +171% | +$290K | 0.01% | 763 |
|
|
2019
Q4 | $244K | Buy |
+3,999
| New | +$244K | 0.01% | 1105 |
|
|
2019
Q2 | – | Sell |
-7,254
| Closed | -$259K | – | 1319 |
|
|
2019
Q1 | $259K | Buy |
+7,254
| New | +$259K | 0.01% | 1100 |
|
|
2018
Q4 | – | Sell |
-6,202
| Closed | -$275K | – | 1264 |
|
|
2018
Q3 | $275K | Buy |
+6,202
| New | +$275K | 0.01% | 1101 |
|